Real‐world assessment of comprehensive genome profiling impact on clinical outcomes: A single‐institution study in Japan
The effectiveness of the genomically matched therapy based on the CGP panel was unsatisfactory. Expansion of clinical trials and utilization of remote clinical trials are required to ensure that the results of the CGP panel can be fully returned to patients.
Authors
- Makiko Urabe (ORCID: https://orcid.org/0009-0009-8033-3158)
- Takahisa Kawamura (ORCID: https://orcid.org/0000-0001-6611-659X)
- Yugo Kai
- Toru Wakamatsu (ORCID: https://orcid.org/0000-0002-3073-0595)
- Keiichiro Honma (ORCID: https://orcid.org/0000-0001-5193-5891)
- Daisuke Sakai (ORCID: https://orcid.org/0000-0003-4189-9270)
- Tazuko Inoue
- Sachiko Yamamoto
- Yoji Kukita
- Takuji Hayashi (ORCID: https://orcid.org/0000-0003-2030-3087)
- Fumie Fujisawa (ORCID: https://orcid.org/0000-0001-8436-9072)
- Yuko Yamaguchi
- Jun Okuno (ORCID: https://orcid.org/0000-0002-8888-0086)
- Mitsuko Kitasaka
- Naotoshi Sugimoto (ORCID: https://orcid.org/0000-0003-1995-5002)
- Kei Kunimasa (ORCID: https://orcid.org/0000-0002-5241-3486)
- Kazuo Nishimura (ORCID: https://orcid.org/0000-0002-7644-1350)
- Seiji Mabuchi (ORCID: https://orcid.org/0000-0003-1803-1166)
- Tomoyuki Yamasaki
Institutions
- Osaka International Cancer Institute (JP)
- Shiga Medical Center (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/cam4.70249
- Citations
- 5
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 1.43